Fig. 1.
Fig. 1. Cross-linking induced patching and capping of CD15. MM6 cells (1 × 106) were suspended in culture medium containing 10 μg FITC-conjugated anti-CD15 or anti-CD31 MoAb per mL and incubated at 4°C for 20 minutes. Cells were then washed and incubated with F(ab) ′2 fragments of goat anti-mouse IgM (for CD15) or IgG (for CD31) at a concentration of 10 μg/mL at 4°C for 20 minutes. Cells were washed and then warmed to 37°C for 10 minutes and examined by fluorescent microscopy. Shown are phase-fluoresecence pairs (A and B, respectively) for cells incubated with anti-CD15 alone (second row), anti-CD15 plus F(ab) ′2 secondary antibody (third row), and anti-CD31 plus F(ab) ′2 secondary antibody (bottom). The top row shows cells incubated with the F(ab) ′2 secondary antibody in the absence of primary antibody.

Cross-linking induced patching and capping of CD15. MM6 cells (1 × 106) were suspended in culture medium containing 10 μg FITC-conjugated anti-CD15 or anti-CD31 MoAb per mL and incubated at 4°C for 20 minutes. Cells were then washed and incubated with F(ab) ′2 fragments of goat anti-mouse IgM (for CD15) or IgG (for CD31) at a concentration of 10 μg/mL at 4°C for 20 minutes. Cells were washed and then warmed to 37°C for 10 minutes and examined by fluorescent microscopy. Shown are phase-fluoresecence pairs (A and B, respectively) for cells incubated with anti-CD15 alone (second row), anti-CD15 plus F(ab) ′2 secondary antibody (third row), and anti-CD31 plus F(ab) ′2 secondary antibody (bottom). The top row shows cells incubated with the F(ab) ′2 secondary antibody in the absence of primary antibody.

Close Modal

or Create an Account

Close Modal
Close Modal